<International Circulation>:When considering the future of imaging in cardiology， what direction are we heading in， in your experience?

 《国际循环》：以您的经验，心脏病影像学的未来正朝着那个方向发展？

    Dr Sinusas: We are moving towards individualized medicine rather than population medicine and that requires imaging approaches that identify unique features of a patient. They may be imaging， they may be biomarkers or genetic screening that would dictate different therapies for different patients. I think the future， at least for the nuclear field， rests with targeted molecular imaging where one is going to identify particular molecular events in a given patient that would probably precede any manifestation of gross disease. You will be able to identify the disease early and initiate therapy before it is too late.

     Sinusas博士：我们正朝着个体化医学而不是群体医学的方向发展，这需要能够识别患者特质的影像学方法。他们可能是成像、生物标志或者是基因筛选，这些将决定不同患者不同的治疗方法。我认为在将来，至少在核医学领域，可以识别不同病人特定分子事件的分子靶向成像技术将优于疾病的任何临床表现，基于此我们能早期的诊断疾病，开始治疗以免为时过晚。